-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-1 Nef-IN-1
Category | Human immunodeficiency Virus (HIV) |
CAS | 13728-56-8 |
Description | HIV-1 Nef-IN-1, an inhibitor of HIV-1 Nef protein, can effectively compete for Nef-SH3Hck interactions with a Kd of 6.7 μM. |
Product Information
Synonyms | 4-(3-Phenanthryl)butanoic acid; 3-Phenanthrenebutanoic Acid; 3-Phenanthrenebutyric Acid; NSC 92828; 3-(1-Phenanthryl)butanoic acid; 1-Phenanthrenepropanoic acid, β-methyl- |
IUPAC Name | 4-phenanthren-3-ylbutanoic acid |
Molecular Weight | 264.32 |
Molecular Formula | C18H16O2 |
Canonical SMILES | C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)CCCC(=O)O |
InChI | InChI=1S/C18H16O2/c19-18(20)7-3-4-13-8-9-15-11-10-14-5-1-2-6-16(14)17(15)12-13/h1-2,5-6,8-12H,3-4,7H2,(H,19,20) |
InChIKey | NYIVWTWKIQOBKO-UHFFFAOYSA-N |
Boiling Point | 487.2±14.0°C (Predicted) |
Melting Point | 138-139°C |
Flash Point | 383.7°C |
Purity | ≥95% |
Density | 1.211±0.06 g/cm3 (Predicted) |
Solubility | Soluble in Chloroform (Slightly), DMSO (Slightly) |
Appearance | Pale Yellow to Light Yellow Solid |
Storage | Store at -20°C |
Index Of Refraction | 1.678 |
In Vitro | HIV-1 Nef-IN-1 (Compound D11; 20 μM) inhibits cell viability of COS7 cells, and the cell inhibition rate is 63.2. |
PSA | 37.30000 |
Target | HIV-1 Nef:6.7 μM (Kd) |
Vapor Pressure | 2.63E-10mmHg at 25°C |